The deal hands Genmab a drug that showed the potential in earlier testing to extend survival in head and neck cancer when ...

Walmsley, who helped push GSK to focus more exclusively on specialty medicines and oncology, will be succeeded by commercial ...

Anticipated late-stage results in the skin disease hidradenitis suppurativa were described by analysts as “disappointing” and ...

Learn how softgels have helped sponsors across the industry improve the efficacy and stability of their therapeutics.